In vivo and vitro experiments show that long noncoding RNA treatment alleviates pathological cardiac hypertrophy

In a recent study, the regulatory role of the long noncoding RNA (lncRNA) Gm20257 in pathological cardiac hypertrophy has been elucidated, offering new insights into potential therapeutic targets. Pathological cardiac hypertrophy, a condition characterized by an abnormal increase in heart muscle size, can lead to heart failure if left unchecked.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup